The acupuncture treatment resulted in significant improvement in total sleep time (time in bed that subjects actually spent sleeping).
We observed decreases in total sleep time during the 1 h following the end of the light pulse.
Symptoms include an increase in total sleep time, nonspecific behavioural difficulties, hyperactivity, irritability, bed-wetting and morning headaches.
Oral treatment with oxcarbazepine (100 mg/kg) produced an increment in total sleep time throughout the recording period.
Objective data show that insomnia medications, on average, provide a gain of only ten or twenty minutes in total sleep time.
During baseline, there were only minor sporadic differences in total sleep time between Afh homozygous mutants and wild-types (Fig. 7a, Table 1).
Relative spectral power of sleep, delta power in particular, was similar in both groups, assessed in total sleep time as well as in first half of it.
The decrease in total sleep after stroke was the result of dramatic reduction in the amount of REM sleep after ischemia.
There was no significant difference in total sleep time (TST), sleep efficiency (SE%), and slow-wave activity (SWA) between the two conditions.
The increase in total sleep time resulted in an increase in the sleep efficiency index, on average from 78.2±6.7 to 83.3±6.7, and was associated with increases in stage 2 and slow wave sleep.
Compared to placebo, gaboxadol produced an overall increase in total sleep time, of approximately 25 min, which was related to a decrease in wakefulness, particularly in wakefulness after sleep onset, and a reduction in the number of awakenings.
